The stock of Cibus Inc (CBUS) has gone down by -10.24% for the week, with a -31.02% drop in the past month and a -32.27% drop in the past quarter. The volatility ratio for the week is 2.07%, and the volatility levels for the past 30 days are 13.05% for CBUS. The simple moving average for the last 20 days is -38.54% for CBUS stock, with a simple moving average of -51.66% for the last 200 days.
Is It Worth Investing in Cibus Inc (NASDAQ: CBUS) Right Now?
The 36-month beta value for CBUS is also noteworthy at 1.84. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for CBUS is 33.91M, and at present, short sellers hold a 5.16% of that float. The average trading volume of CBUS on June 13, 2025 was 293.98K shares.
CBUS) stock’s latest price update
Cibus Inc (NASDAQ: CBUS)’s stock price has decreased by -6.88 compared to its previous closing price of 1.60. However, the company has seen a -10.24% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-12 that Researchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration with the potential to introduce the trait into several commercial crops Cibus previously announced the successful editing of Canola plants with this mutation and looks forward to further testing and trait validation SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (“Cibus” or the “Company”) (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today confirmed its continuing collaboration with the John Innes Centre (JIC). Cibus applauds the JIC breakthrough discovery, published earlier this year in the journal Nature, of a biological mechanism that makes plant roots more welcoming to beneficial soil microbes.
Analysts’ Opinion of CBUS
Many brokerage firms have already submitted their reports for CBUS stocks, with Alliance Global Partners repeating the rating for CBUS by listing it as a “Buy.” The predicted price for CBUS in the upcoming period, according to Alliance Global Partners is $25 based on the research report published on July 29, 2024 of the previous year 2024.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see CBUS reach a price target of $22. The rating they have provided for CBUS stocks is “Buy” according to the report published on July 19th, 2024.
H.C. Wainwright gave a rating of “Buy” to CBUS, setting the target price at $25 in the report published on October 09th of the previous year.
CBUS Trading at -30.66% from the 50-Day Moving Average
After a stumble in the market that brought CBUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.17% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CBUS starting from Prante Gerhard, who sale 1,150 shares at the price of $1.92 back on Feb 25 ’25. After this action, Prante Gerhard now owns 7,707 shares of Cibus Inc, valued at $2,208 using the latest closing price.
Prante Gerhard, the Director of Cibus Inc, sale 1,150 shares at $2.07 during a trade that took place back on Feb 24 ’25, which means that Prante Gerhard is holding 8,857 shares at $2,380 based on the most recent closing price.
Stock Fundamentals for CBUS
Current profitability levels for the company are sitting at:
- -59.25 for the present operating margin
- 0.64 for the gross margin
The net margin for Cibus Inc stands at -57.85. The total capital return value is set at -0.9. Equity return is now at value -157.73, with -63.32 for asset returns.
Based on Cibus Inc (CBUS), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at -2.27. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is -8.22.
Currently, EBITDA for the company is -241.63 million with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 12.85. The receivables turnover for the company is 5.0for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.23.
Conclusion
In summary, Cibus Inc (CBUS) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
